MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 310 participants.

Also called NCT01869738

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 310 participants (enrolled count) (from the registry)
Sponsor
  • InspireMD Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01869738
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Belgium, Czechia, Estonia, Finland, France, Germany, Israel, Netherlands, Poland, Spain, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01869738. Randomized; single masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction
Acronym
MASTER-II
Condition
ST Elevation Myocardial Infarction
Intervention (Device)
MGuard Prime
Intervention (Device)
(BMS/DES)
Lead sponsor
InspireMD (class: industry)

Record details

Record id
cardio:ct-nct01869738
Content hash
305d2f26813e9e97d130127662ec93c4b1e589714ea0e75b10098bfad2934fd1